•
Sep 30, 2023

Pliant Therapeutics Q3 2023 Earnings Report

Total Revenue
$0
Previous year: $1.48M
-100.0%
EPS
-$0.7
Previous year: -$0.65
+7.7%
Gross Profit
-$1.05M
Previous year: $452K
-331.2%
Cash and Equivalents
$524M
Previous year: $44.6M
+1073.6%
Free Cash Flow
-$36.3M
Previous year: -$19.2M
+89.2%
Total Assets
$540M
Previous year: $377M
+43.3%

Pliant Therapeutics

Pliant Therapeutics